These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25407099)

  • 1. Sublingual allergen immunotherapy for respiratory allergies: what is new?
    Makatsori M; Calderon MA
    Expert Rev Clin Immunol; 2014 Dec; 10(12):1641-7. PubMed ID: 25407099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sublingual immunotherapy in children: the recent experiences.
    Pleskovic N; Bartholow A; Skoner DP
    Curr Opin Allergy Clin Immunol; 2014 Dec; 14(6):582-90. PubMed ID: 25188717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New developments in allergen immunotherapy.
    Vadlamudi A; Shaker M
    Curr Opin Pediatr; 2015 Oct; 27(5):649-55. PubMed ID: 26241500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The global development and clinical efficacy of sublingual tablet immunotherapy for allergic diseases.
    Nolte H; Maloney J
    Allergol Int; 2018 Jul; 67(3):301-308. PubMed ID: 29759659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical relevance of non-grass pollens respiratory allergies in Italy and effects of specific sublingual immunotherapy: The Rainbow Trial, a multicentre 3-year prospective observational study.
    Milani M; Pecora S;
    Eur Ann Allergy Clin Immunol; 2011 Aug; 43(4):111-6. PubMed ID: 21980798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
    Calderon MA; Casale TB; Nelson HS; Demoly P
    J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy.
    Kiel MA; Röder E; Gerth van Wijk R; Al MJ; Hop WC; Rutten-van Mölken MP
    J Allergy Clin Immunol; 2013 Aug; 132(2):353-60.e2. PubMed ID: 23651609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sublingual immunotherapy: the U.S. experience.
    Nelson HS
    Curr Opin Allergy Clin Immunol; 2013 Dec; 13(6):663-8. PubMed ID: 24169432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of sublingual immunotherapy for allergic asthma: retrospective meta-analysis of randomized, double-blind and placebo-controlled trials.
    Tao L; Shi B; Shi G; Wan H
    Clin Respir J; 2014 Apr; 8(2):192-205. PubMed ID: 24118881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized double-blind placebo-controlled trial of sublingual immunotherapy in children with house dust mite allergy in primary care: study design and recruitment.
    de Bot CM; Moed H; Berger MY; Röder E; de Groot H; de Jongste JC; van Wijk RG; van der Wouden JC
    BMC Fam Pract; 2008 Oct; 9():59. PubMed ID: 18937864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
    Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB
    Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sublingual immunotherapy: what we can learn from the European experience.
    Linkov G; Toskala E
    Curr Opin Otolaryngol Head Neck Surg; 2014 Jun; 22(3):208-10. PubMed ID: 24801802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sublingual Immunotherapy Dosing Regimens: What Is Ideal?
    Jin JJ; Li JT; Klimek L; Pfaar O
    J Allergy Clin Immunol Pract; 2017; 5(1):1-10. PubMed ID: 28065336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five-grass-pollen sublingual immunotherapy tablet for the treatment of grass-pollen-induced allergic rhinoconjunctivitis: 5 years of experience.
    Didier A; Wahn U; Horak F; Cox LS
    Expert Rev Clin Immunol; 2014 Oct; 10(10):1309-24. PubMed ID: 25205329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sublingual immunotherapy for allergic rhinitis: where are we now?
    Incorvaia C; Mauro M; Ridolo E
    Immunotherapy; 2015; 7(10):1105-10. PubMed ID: 26507464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of sublingual allergen immunotherapy.
    DuBuske L
    Allergy Asthma Proc; 2022 Jul; 43(4):272-280. PubMed ID: 35818141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sublingual Immunotherapy for the Polyallergic Patient.
    Pepper AN; Calderón MA; Casale TB
    J Allergy Clin Immunol Pract; 2017; 5(1):41-45. PubMed ID: 27452888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controversies in Allergy: A Pro/Con Review of Sublingual Allergen Immunotherapy and Allergic Asthma.
    Calderón MA; Bacharier LB
    J Allergy Clin Immunol Pract; 2021 May; 9(5):1818-1825. PubMed ID: 33652134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of patients for sublingual versus subcutaneous immunotherapy.
    Larenas Linnemann DE; Blaiss MS
    Immunotherapy; 2014; 6(7):871-84. PubMed ID: 25290418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind, placebo-controlled study with sublingual immunotherapy in children with seasonal allergic rhinitis to grass pollen.
    Wüthrich B; Bucher Ch; Jörg W; Bircher A; Eng P; Schneider Y; Schnyder F; Eigenmann P; Senti G
    J Investig Allergol Clin Immunol; 2003; 13(3):145-8. PubMed ID: 14635462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.